Hjalmar Flygt
5PUBLICATIONS
11CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Feb 28, 2024
Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.Hjalmar Flygt, Stina Söderlund, Johan Richter
|Jan 26, 2024
Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib - interim results from the DAstop2 trial.Hjalmar Flygt, Stina Söderlund, Johan Richter
|Jan 11, 2022
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: Follow-up of patients diagnosed 2002-2017 in a complete coverage and nationwide agnostic register study.Torsten Dahlén, Gustaf Edgren, Per Ljungman
|Aug 21, 2021
Long-term tolerability and efficacy after initial PegIFN-α addition to dasatinib in CML-CP: Five-year follow-up of the NordCML007 study.Hjalmar Flygt, Stina Söderlund, Jesper Stentoft
|Mar 30, 2021
Successful tyrosine kinase inhibitor discontinuation outside clinical trials - data from the population-based Swedish chronic myeloid leukaemia registry.Hjalmar Flygt, Fredrik Sandin, Torsten Dahlén
Pageof 1
Frequent Collaborators
3 joint publications
Johan Richter
2 joint publications
Susanne Saussele
2 joint publications
Satu Mustjoki
2 joint publications
Andreja Dimitrijevic
1 joint publications
Torsten Dahlén
1 joint publications
Gustaf Edgren
1 joint publications
Per Ljungman
1 joint publications
Jingcheng Zhao
1 joint publications
Anders Själander
1 joint publications
Martin Höglund
